Fisher Ryan C. sold $200K of NGVT

Fisher Ryan C. (SVP, Gen. Counsel & Secretary) sold 2,709 shares of Ingevity Corp (NGVT) at an average of $73.72 ($73.67–$73.76, $0.20M total) across 2 trades on 2026-08-03.

Original reporting
SEC EDGAR · Fisher Ryan C.
Published Aug 4, 2026, 9:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NGVT
Neutral
medium confidence
Mentioned
$NGVT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NGVTNeutralLow
01

Why it matters

A named officer sold 2,709 shares at roughly $73.67 to $73.76, totaling about $199.7K, with holdings after the sale of 15,722 shares.

02

Market read

Traders may note the insider sale for sentiment, but there is no new operational or financial information.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; the article lacks any accompanying narrative or follow-on buying.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-04 after-hours; transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for Ingevity (NGVT).

Company-level read

Ticker impact

$NGVTNeutralMedium confidence
Context

Ingevity insider Ryan Fisher sold about $199.7K of NGVT shares via an open-market sale reported on SEC Form 4.

Expected impact

Likely minimal near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing provides transaction size, price range, and role, but no earnings, guidance, deal, or regulatory catalyst. Insider sales are common and often not predictive without additional context.

Market effects

No clear sector read-through from a single, small insider sale.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • Ingevity Corp

    Company whose insider transaction is disclosed on SEC Form 4.

  • Ryan C. Fisher

    SVP, General Counsel & Secretary who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NGVTMed

Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?

Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.

$NGVTHighAI 8/10

Ingevity Q3 Earnings Call Highlights

Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.

$NGVTMed

Ingevity (NGVT) Q3 2026 Earnings Call Transcript

Ingevity (NGVT) reported Q3 2026 sales of $305M, down 8% YoY due to divestitures, but up 2% excluding them. Adjusted EBITDA was $108M, down 2%, with margins expanding to 35.4%. EPS rose 24% to $1.63. The company highlighted growth in filtration and water treatment, secured new contracts, and repurchased $39M in shares. Full-year adjusted EBITDA is expected to be $385M-$395M, with sales around $1.1B and EPS of $5.25-$5.45.

$NGVTMed

Ingevity reports third quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports third quarter 2026 financial results Third Quarter 2026 Results and Recent Highlights: • Net sales of $305.1 million decreased 8% from prior year; exclu

$NGVTHigh

Ingevity reports third quarter 2026 financial results

Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.